Faslodex (fulvestrant) Solution for Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) March 2016 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity Based on findings from animal studies and its mechanism of action,...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts